 |
| 18-Jun-13 | Reiterated |
Dougherty & Company |
Buy |
$15 → $20 |
|
| 17-Jun-13 | Reiterated |
Feltl & Co. |
Strong Buy |
$17 → $20 |
|
| 09-Apr-13 | Initiated |
Feltl & Co. |
Strong Buy |
$15 |
|
| 10-May-12 | Reiterated |
Dougherty & Company |
Buy |
$10 → $13 |
|
| 28-Sep-11 | Initiated |
BB&T Capital Mkts |
Buy |
$10 |
|
| 04-Aug-09 | Upgrade |
Piper Jaffray |
Neutral → Overweight |
|
|
| 12-Sep-08 | Downgrade |
Piper Jaffray |
Buy → Neutral |
|
|
| 13-Aug-08 | Initiated |
Noble Financial |
Buy |
$6.50 |
|
| 06-May-08 | Reiterated |
Broadpoint Capital |
Buy |
$9 → $6 |
|
| 30-Apr-08 | Reiterated |
Dougherty & Company |
Buy |
$15 → $8 |
|
| 15-Feb-08 | Upgrade |
Broadpoint Capital |
Neutral → Buy |
$9 |
|
| 15-Oct-07 | Downgrade |
Broadpoint Capital |
Buy → Neutral |
|
|
| 28-Jun-07 | Upgrade |
Piper Jaffray |
Market Perform → Outperform |
|
|
| 07-May-07 | Reiterated |
First Albany |
Buy |
$4 → $6 |
|
|
|
| 18-Jun-13 02:00PM | BioScrip Grows with CarePoint Buyout Zacks |
| 10:07AM | BIOSCRIP, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure EDGAR Online |
| 17-Jun-13 03:22PM | 4 Merger and Acquisitions Stock Stories Causing a Monday Buzz at Wall St. Cheat Sheet +5.27% |
| 01:42PM | BioScrip will buy drug infusion company for $223M AP |
| 10:15AM | BIOSCRIP, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 10:10AM | Tesla Rides a New Upgrade, BioScrip Buys CarePoint, and 3 More Hot Stocks at Wall St. Cheat Sheet |
| 08:05AM | BioScrip Extends The Consent Payment Deadline And Expiration Date For Its Previously Announced Tender Offer And Consent Solicitation PR Newswire |
| 08:04AM | InPlay: Bioscrip to acquire CarePoint Partners Home Infusion business for $223 mln Briefing.com |
| 08:00AM | BioScrip To Acquire CarePoint Partners Home Infusion Business PR Newswire |
| 06-Jun-13 09:01AM | Has BioScrip Made You Any Fast Money? at Motley Fool |
| 03-Jun-13 04:34PM | InPlay: Bioscrip announces tender offer and consent solicitation for outstanding $225 mln of 10.25% Senior Notes due 2015 Briefing.com |
| 04:32PM | BioScrip Announces Tender Offer And Consent Solicitation PR Newswire |
| 10:37AM | BIOSCRIP, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 28-May-13 11:14AM | [video] Where to Find Tomorrow's Growth Stocks at MarketWatch |
| 25-May-13 05:31AM | [$$] Where to Find Tomorrow's Growth Stocks at Barrons.com |
| 23-May-13 04:30PM | BioScrip To Present At Jefferies 2013 Global Healthcare Conference PR Newswire |
| 12:00PM | Do These Tuesday Upgrades Present a Buying Opportunity? at Motley Fool |
| 21-May-13 06:15PM | Shorts Are Covering 3 Stocks Undervalued By EPS Trends at TheStreet |
| 05:53PM | Movers roundup: Tesla, BioScrip AP |
| 02:28PM | BioScrip rises on positive analyst expectations AP |
| 15-May-13 01:04PM | BIOSCRIP, INC. Financials EDGAR Online Financials |
| 14-May-13 03:55PM | Prominent Hedge Fund Prescott Group Buying Some Little-Known Plays at Seeking Alpha |
| 01:04AM | Are You Missing Something Easy at BioScrip? at Motley Fool |
| 13-May-13 07:15AM | Investing In Pharmacy Stocks Could Be The Next Major Play at Seeking Alpha |
| 04:13AM | BIOSCRIP, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online |
| 10-May-13 04:08PM | Short Interest Falls 22.7% For BIOS at TheStreet |
| 09-May-13 11:10AM | BioScrip Management Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha |
| 08:50AM | BIOS Misses Earnings Mark But Rev Tops Zacks |
| 08:33AM | BIOSCRIP, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 08:30AM | BioScrip Earnings Call scheduled for 8:30 am ET today CCBN |
| 07:34AM | BioScrip Earnings Call scheduled for 8:30 am ET today CCBN |
| 08-May-13 07:16PM | BioScrip Earnings: Heres Why Investors are Excited Now at Wall St. Cheat Sheet |
| 05:31PM | InPlay: Bioscrip beats by $0.02, beats on revs; reaffirms FY13 revs guidance Briefing.com |
| 05:26PM | BioScrip Reports First Quarter 2013 Financial Results PR Newswire |
| 12:04PM | BioScrip Earnings: What Investors Should Watch at Wall St. Cheat Sheet |
| 10:32AM | BIOSCRIP, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements EDGAR Online |
| 07:07AM | Q1 2013 BioScrip Earnings Release - After Market Close CCBN |
| 01-May-13 02:06PM | Looking Into The Specialty Pharmacy Sector at Seeking Alpha |
| 10:20AM | Sluggish Segments Sour CVS Earnings Beat Zacks |
| 30-Apr-13 11:45AM | Low Cost of Capital, Revenue Replacement for Drugs That Lost Patent Protection are Major Drivers of M&A in the Pharma Space Wall Street Transcript |
| 25-Apr-13 04:30PM | BioScrip to Host First Quarter 2013 Earnings Call PR Newswire |
| 24-Apr-13 04:35PM | BioScrip Closes Underwritten Offering Of Common Stock PR Newswire |
| 22-Apr-13 06:03PM | Nasdaq stocks posting largest volume increases AP |
| 21-Apr-13 11:02PM | BIOSCRIP, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and EDGAR Online |
| 19-Apr-13 06:06PM | Nasdaq stocks posting largest volume increases AP +5.32% |
| 06:00PM | BioScrip Prices New Stock Issue at Motley Fool |
| 08:52AM | InPlay: Bioscrip prices 12.5 mln share offering at $12.00 per share Briefing.com |
| 08:51AM | BioScrip Prices Underwritten Offering of Common Stock PR Newswire |
| 08:05AM | BioScrip 12.5M share Secondary priced at $12.00 theflyonthewall.com |
| 16-Apr-13 04:56PM | BioScrip Announces Proposed Refinancing of Existing Indebtedness PR Newswire |
| 04:39PM | InPlay: Bioscrip announces proposed public offering of common stock, size not disclosed Briefing.com |
| 04:38PM | BioScrip Announces Proposed Public Offering of Common Stock PR Newswire |
| 10:21AM | BIOSCRIP, INC. Files SEC form 8-K, Other Events EDGAR Online |
| 15-Apr-13 02:04PM | Specialty Pharmacies: An Overlooked Segment In A Profitable Industry at Seeking Alpha |
| 11-Apr-13 07:51AM | The Zacks Analyst Blog Highlights: Microsoft, VMware, Apple, Google and BioScrip Zacks |
| 10-Apr-13 04:31PM | BioScrip Raised to Outperform Zacks |
| 08:39AM | BioScrip Initiated with Strong Buy and 2 Stocks at 52-Week Highs on Tuesday at Wall St. Cheat Sheet |
| 09-Apr-13 02:09PM | Intuitive Surgical is a Buy and 3 More Analyst Notes to Read at Wall St. Cheat Sheet |
| 03:29AM | Coverage initiated on Bioscrip by Feltl & Co. Briefing.com |
| 05-Apr-13 04:03AM | BIOSCRIP, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online |
| 04-Apr-13 09:20AM | BioScrip initiated with a Neutral at Sidoti theflyonthewall.com |
| 01-Apr-13 10:50AM | Retiring Baby Boomers Signal A Boom In Assisted Living at Seeking Alpha |
| 20-Mar-13 01:04PM | BIOSCRIP, INC. Financials EDGAR Online Financials |
| 16-Mar-13 04:36PM | 4 Winners and 1 Loser from This Weeks Earnings Storm at Wall St. Cheat Sheet |
| 15-Mar-13 06:02AM | BIOSCRIP, INC. Files SEC form 10-K, Annual Report EDGAR Online |
| 14-Mar-13 05:14PM | BIOSCRIP, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online |
| 08:24AM | Zacks Rank #1 Addition for Thursday Zacks |
| 13-Mar-13 03:52PM | 3 Post-Earning Outlooks for Top Movers at Motley Fool +5.13% |
| 01:22PM | Nasdaq stocks posting largest percentage increases AP |
| 12-Mar-13 08:31PM | New Star Analyst Rankings for BioScrip, Inc. StarMine +12.57% |
| 07:18PM | On The Fly: After Hours Movers theflyonthewall.com |
| 06:03PM | Nasdaq stocks posting largest percentage increases AP |
| 01:16PM | Nasdaq stocks posting largest percentage increases AP |
| 12:54PM | Why BioScrip Shares Rallied at Motley Fool |
| 11:30AM | BioScrip Management Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha |
| 08:38AM | BioScrip Beats; Avid FY13 Outlook Zacks |
| 08:30AM | BioScrip Earnings Call scheduled for 8:30 am ET today CCBN |
| 08:19AM | BioScrip Earnings Call scheduled for 8:30 am ET today CCBN |
| 11-Mar-13 07:02PM | On The Fly: After Hours Movers theflyonthewall.com |
| 06:12PM | BioScrip Earnings: Heres Why the Stock is Rising Now at Wall St. Cheat Sheet |
| 05:48PM | InPlay: Bioscrip beats by $0.03, beats on revs; guides FY13 revs above consensus Briefing.com |
| 05:24PM | BIOSCRIP, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements EDGAR Online |
| 04:44PM | BioScrip Reports Fourth Quarter 2012 Financial Results PR Newswire |
| 07:07AM | Q4 2012 BioScrip Earnings Release - After Market Close CCBN |
| 06-Mar-13 04:00AM | BioScrip Inc. Stock Downgraded (BIOS) at TheStreet |
| 20-Feb-13 02:18PM | BioScrip Reaffirmed at Neutral Zacks |
| 19-Feb-13 04:30PM | BioScrip To Host Fourth Quarter And Year-End 2012 Earnings Call PR Newswire |
| 12-Feb-13 12:49PM | [$$] Health Care Takeover Targets at Barrons.com |
| 11:21AM | [$$] Healthcare Takeover Targets at Barrons.com |
| 10-Feb-13 01:14PM | BioScrip Turns More Into Less at Motley Fool |
| 04-Feb-13 05:23PM | BIOSCRIP, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Other Events, Financial Statem EDGAR Online |
| 01:21PM | BioScrip Closes $70 Million Purchase of HomeChoice Partners at Motley Fool |
| 09:30AM | BioScrip completes $70M acquisition of HomeChoice AP |
| 08:00AM | BioScrip Closes Acquisition of HomeChoice Partners, Inc. PR Newswire |
| 28-Jan-13 11:41AM | Three questions with Polsinelli Shugharts Randy Gerber at bizjournals.com |
| 21-Jan-13 02:18PM | Still Neutral on Walgreens Zacks |
| 17-Jan-13 08:30AM | BioScrip To Present At "NINE" Noble Financial Capital Markets' Ninth Annual Equity Conference PR Newswire |
| 14-Jan-13 06:40PM | [video] Lightning Round at CNBC |
| 06:35PM | Lightning Round: Fortress, GNC & More at CNBC |
| 21-Dec-12 05:02AM | Is BioScrip Making You Fast Cash? at Motley Fool |
|
|
| BioScrip, Inc. provides home infusion and other home care services, and pharmacy benefit management (PBM) services in the United States. It operates in three segments: Infusion Services, Home Health Services, and PBM Services. The Infusion Services segment offers home infusion therapy and respiratory therapy services; and durable medical equipment, products, and services. Its home infusion services include the intravenous administration of medications to treat various acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic conditions, cancer, pain, and palliative care. This segment offers services, including the dispensing and administering of infusion-based drugs, which require nursing and clinical management services; equipment to administer the dosage; patient training; and dispensing of self-injectible therapies. The Home Health Services segment provides skilled nursing, wound care, oncology nursing and infusion nursing, rehabilitation services, occupational therapy and speech language pathology, medical social services, home health aide services, private duty nursing care, intermittent nursing care, therapy visits, and hospice services to adult and pediatric patients in their homes, including patients suffering from chronic and acute illnesses, patients in recovery from surgical procedures, and who require monitoring or care for other reasons. The PBM Services segment offers discount card programs that provide an alternative for individuals who may be uninsured, underinsured, or may have restrictive coverage that disallows reimbursement for certain medications. The company was formerly known as MIM Corporation and changed its name to BioScrip Inc. as a result of its merger with Chronimed Inc. in March 2005. BioScrip Inc. was founded in 1993 and is headquartered in Minnetonka, Minnesota. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| HOLUBIAK MYRON Z | Director | Dec 14 | Sale | 10.82 | 10,000 | 108,232 | 20,000 | Dec 18 12:17 PM | | SAMUELS STUART A | Director | Nov 13 | Option Exercise | 4.43 | 11,200 | 49,616 | 57,700 | Nov 15 11:37 AM | | SAMUELS STUART A | Director | Nov 13 | Sale | 9.66 | 11,200 | 108,228 | 46,500 | Nov 15 11:37 AM | | HOLUBIAK MYRON Z | Director | Sep 07 | Option Exercise | 4.28 | 1,200 | 5,136 | 31,200 | Sep 10 02:51 PM | | HOLUBIAK MYRON Z | Director | Sep 07 | Sale | 8.50 | 1,200 | 10,200 | 30,000 | Sep 10 02:51 PM | | HOLUBIAK MYRON Z | Director | Sep 06 | Option Exercise | 4.28 | 8,400 | 35,952 | 38,400 | Sep 10 02:51 PM | | HOLUBIAK MYRON Z | Director | Sep 06 | Sale | 8.51 | 8,400 | 71,469 | 30,000 | Sep 10 02:51 PM | | HOLUBIAK MYRON Z | Director | Sep 04 | Option Exercise | 4.28 | 100 | 428 | 30,100 | Sep 05 06:32 PM | | HOLUBIAK MYRON Z | Director | Sep 04 | Sale | 8.50 | 100 | 850 | 30,000 | Sep 05 06:32 PM | | HOLUBIAK MYRON Z | Director | Aug 31 | Option Exercise | 4.34 | 6,700 | 29,096 | 33,900 | Sep 05 06:32 PM | | HOLUBIAK MYRON Z | Director | Aug 31 | Sale | 8.50 | 6,700 | 56,983 | 30,000 | Sep 05 06:32 PM |
|
|
|
|
|
|
